Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Tilia Bioconsulting AB
AB
In liquidation
Org 5591272686
Research and experimental development on biotechnology
· NACE 7211
Est. 2017
0 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on biotechnology
/
Tilia Bioconsulting AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2018
0M
2019
0M
2020
0M
2021
0M
2022
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2018
0M
2019
0M
2020
0M
2021
0M
2022
Income statement
SEK thousands
Item
2018
2019
2020
2021
2022
Revenue
380
295
50
334
102
Staff expenses
—
—
—
—
—
EBITDA
334
274
17
318
86
Depreciation & amort.
−0
−0
−0
−0
—
EBIT
334
274
17
318
86
Net financials
—
—
—
—
0
Profit before tax
333
274
17
293
86
Tax
−73
−59
−4
−60
−18
Net profit
260
215
13
233
68
Balance sheet
SEK thousands
Item
2018
2019
2020
2021
2022
Total assets
320
372
155
434
200
Equity
310
325
138
321
160
Long-term debt
0
0
0
0
—
Short-term debt
10
47
16
87
15
Total debt
10
47
16
87
15
Financial ratios
5-year trend
EBITDA margin
84.4%
This company
15.8%
Market median
+434% vs market
2018
2022
Equity ratio
80.0%
This company
38.2%
Market median
+109% vs market
2018
2022
Return on equity
42.8%
This company
18.4%
Market median
+133% vs market
2018
2022
Net profit margin
67.0%
This company
8.1%
Market median
+727% vs market
2018
2022
Asset turnover
0.51×
This company
1.12×
Market median
-54% vs market
2018
2022
Debt / equity
0.25×
This company
0.62×
Market median
+60% vs market
2018
2022
Annual reports & filings
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via Bolagsverket / SCB · Period 2017-09-01 – 2018-12-31
View
PDF
More on Tilia Bioconsulting AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
